Table of contents


Top

Editorial

The genome-assisted barnyard p487

doi:10.1038/nbt0609-487

In contrast to the slow translation of human genome information into medicine, animal genomics is likely to have a rapid and tangible impact on agriculture.


Top

News

Flu vaccine makers upgrade technology—and pray for time pp489 - 491

Cormac Sheridan

doi:10.1038/nbt0609-489


Taiwan builds biotech runway p490

Susan Aldridge

doi:10.1038/nbt0609-490


Profiting from pandemics p491

Brady Huggett

doi:10.1038/nbt0609-491


Boardroom tensions rise as investors push for liquidation pp492 - 493

Brian Orelli

doi:10.1038/nbt0609-492


Still strapped for cash p493

Brady Huggett

doi:10.1038/nbt0609-493


Mixed news for Avastin p494

George S Mack

doi:10.1038/nbt0609-494a


Ariad's NFkappaB patent claims shot down on appeal pp494 - 495

Ken Garber

doi:10.1038/nbt0609-494b


TNF-blocker triple approval p495

James Netterwald

doi:10.1038/nbt0609-495


Phase zero launch p496

Emma Dorey

doi:10.1038/nbt0609-496a


Pig patent revolt p496

Anna Meldolesi

doi:10.1038/nbt0609-496b


US regulator wades into stem cell therapies for heart disease pp496 - 498

Randy Osborne

doi:10.1038/nbt0609-496c


Genzyme takes Campath bet p498

Brady Huggett

doi:10.1038/nbt0609-498a


India's first true stem cell trials p498

Killugudi Jayaraman

doi:10.1038/nbt0609-498b


News Feature

Vaccine market boosters pp499 - 501

Cormac Sheridan

doi:10.1038/nbt0609-499

Recent commercial success belies conventional wisdom that vaccines are a low-margin, moribund sector. But will the trend continue? Cormac Sheridan investigates.


Top

Bioentrepreneur

Building a business

Can you hear me in the back? pp502 - 503

Carin Canale

doi:10.1038/bioe.2009.4


Top

Opinion and Comment

Correspondence

Pharma's role is not to bankroll biotech p504

Martin Mackay

doi:10.1038/nbt0609-504a


Conflating MTAs and patents pp504 - 505

Kevin E Noonan

doi:10.1038/nbt0609-504b


Reply to Conflating MTAs and patents p505

doi:10.1038/nbt0609-505


First GM trial in Belgium since 2002 p506

René Custers

doi:10.1038/nbt0609-506


A European perspective on immunogenicity evaluation pp507 - 508

Christian K Schneider, Marisa Papaluca & Pekka Kurki

doi:10.1038/nbt0609-507


Reflect: augmented browsing for the life scientist pp508 - 510

Evangelos Pafilis, Seán I O'Donoghue, Lars J Jensen, Heiko Horn, Michael Kuhn, Nigel P Brown & Reinhard Schneider

doi:10.1038/nbt0609-508


Extrapolating from sequence—the 2009 H1N1 'swine' influenza virus pp510 - 513

Venkataramanan Soundararajan, Kannan Tharakaraman, Rahul Raman, S Raguram, Zachary Shriver, V Sasisekharan & Ram Sasisekharan

doi:10.1038/nbt0609-510


Commentary

Science communication reconsidered pp514 - 518

Tania Bubela, Matthew C Nisbet, Rick Borchelt, Fern Brunger, Cristine Critchley, Edna Einsiedel, Gail Geller, Anil Gupta, Jürgen Hampel, Robyn Hyde-Lay, Eric W Jandciu, S Ashley Jones, Pam Kolopack, Summer Lane, Tim Lougheed, Brigitte Nerlich, Ubaka Ogbogu, Kathleen O'Riordan, Colin Ouellette, Mike Spear, Stephen Strauss, Thushaanthini Thavaratnam, Lisa Willemse & Timothy Caulfield

doi:10.1038/nbt0609-514

As new media proliferate and the public's trust and engagement in science are influenced by industry involvement in academic research, an interdisciplinary workshop provides some recommendations to enhance science communication.


Strangled at birth? Forest biotech and the Convention on Biological Diversity pp519 - 527

Steven H. Strauss, Huimin Tan, Wout Boerjan & Roger Sedjo

doi:10.1038/nbt0609-519

Against the Cartagena Protocol and widespread scientific support for a case-by-case approach to regulation, the Convention on Biological Diversity has become a platform for imposing broad restrictions on research and development of all types of transgenic trees.


Top

Features

Masters of their universe pp528 - 530

Randy Osborne & Laura DeFrancesco

doi:10.1038/nbt0609-528

Nature Biotechnology talks to some of the leading characters behind the Genentech legend.


Wasting cash—the decline of the British biotech sector pp531 - 537

Graham Smith, Muhammad Safwan Akram, Keith Redpath & William Bains

doi:10.1038/nbt0609-531

Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.


Patents

A day late and a few million dollars short pp538 - 541

Dianna Goldenson

doi:10.1038/nbt0609-538

The pitfalls of seeking and obtaining a patent term extension.


Recent patent applications in genomic assays p542

doi:10.1038/nbt0609-542


Top

News and Views

Shining light on a new class of hydrogels pp543 - 544

Steven M Jay & W Mark Saltzman

doi:10.1038/nbt0609-543

Addition of a photodegradable group to the backbone of synthetic hydrogels enables real-time control of the material's chemical and physical properties.


Cause and express pp544 - 545

Leonid Kruglyak & John D Storey

doi:10.1038/nbt0609-544

Biological validation of a cadre of new obesity genes supports the power of studies that exploit 'expression quantitative trait loci'.


Structure of a multidrug transporter pp546 - 547

Michael M Gottesman, Suresh V Ambudkar & Di Xia

doi:10.1038/nbt0609-546

Crystal structures of a mammalian multidrug efflux pump bound to peptide inhibitors may reveal drug-binding sites.


Top

Research Highlights

Research highlights p548

doi:10.1038/nbt0609-548


Top

Computational Biology

Analysis

Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs pp549 - 555

Aly A Khan, Doron Betel, Martin L Miller, Chris Sander, Christina S Leslie & Debora S Marks

doi:10.1038/nbt.1543

Transfection of siRNAs and miRNAs into cells has been observed to generate unexpected effects in the form of gene upregulation. By statistically analyzing published transfection experiments, Khan et al. explain these effects with a model that the transfected RNAs compete with miRNAs naturally expressed by the cell.


Top

Research

Brief Communications

Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture pp557 - 559

Michael T Forrester, J Will Thompson, Matthew W Foster, Leonardo Nogueira, M Arthur Moseley & Jonathan S Stamler

doi:10.1038/nbt.1545

Forrester et al. adapt the biotin switch technique for studying reversible protein modification by nitric oxide, by using resin-assisted capture of S-nitrosothiols. This enables more sensitive detection of larger S-nitrosylated proteins and can be coupled with quantitative mass spectrometry to study the kinetics of denitrosylation.


Article

Genome sequence of the recombinant protein production host Pichia pastoris pp561 - 566

Kristof De Schutter, Yao-Cheng Lin, Petra Tiels, Annelies Van Hecke, Sascha Glinka, Jacqueline Weber-Lehmann, Pierre Rouzé, Yves Van de Peer & Nico Callewaert

doi:10.1038/nbt.1544

Pichia pastoris has been a workhorse of protein production for decades. De Schutter et al. present its genomic sequence, which will allow development of improved strains.


Letters

Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein pp567 - 571

Akiko Eguchi, Bryan R Meade, Yung-Chi Chang, Craig T Fredrickson, Karl Willert, Nitin Puri & Steven F Dowdy

doi:10.1038/nbt.1541

The delivery to primary cells is a major challenge in the application of siRNAs in biological research. Using a fusion protein consisting of a double-stranded RNA binding domain and a protein transduction domain, Eguchi et al. are able to transfect siRNAs into a wide variety of cells with very high efficiency without cytotoxicity.


MicroRNA-mediated species-specific attenuation of influenza A virus pp572 - 576

Jasmine T Perez, Alissa M Pham, Maria H Lorini, Mark A Chua, John Steel & Benjamin R tenOever

doi:10.1038/nbt.1542

Traditional methods for modifying viruses to produce live attenuated vaccines are being updated with molecularly targeted approaches. Perez et al. attenuate influenza A viruses by introducing miRNA target sites into the coding region of the viral genome.


Top

Careers and Recruitment

Careers and Recruitment

Career interrupted p577

Mari Paul

doi:10.1038/nbt0609-577

A sound game plan can help you roll with the punches in uncertain times.


People

People p578

doi:10.1038/nbt0609-578


Top

Extra navigation

Open Innovation Challenges

naturejobs

ADVERTISEMENT